Gut bacteria transplant as a possible treatment for alopecia areata
Part of Skin clinical trials.
This study tests whether transplanting healthy gut bacteria (called a fecal microbiota transplant) can help treat alopecia areata, a condition that causes patchy hair loss. By restoring a balanced gut microbiome, the treatment may reduce inflammation and potentially promote hair regrowth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 65 years old and have been diagnosed with alopecia areata (patchy or extensive hair loss) for up to 10 years.
- You must have at least 20% scalp hair loss as measured by a standard score (SALT).
- You must be willing to receive the treatment, which involves taking capsules or having a colonoscopy.
- You must not have any gut diseases (like inflammatory bowel disease or celiac disease) or take antibiotics, probiotics, or prebiotics in the last 2 months.
- You must not be pregnant or breastfeeding, and if you can become pregnant, you must use birth control.
- You must not have a weakened immune system, serious medical conditions, or severe food allergies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether transplanting healthy gut bacteria can help people with moderate to severe alopecia areata regrow hair. You will take antibiotics to prepare your gut, then receive the transplant through a colonoscopy or capsules.
This trial tests a new drug called FB102 for people with severe to very severe alopecia areata, a condition that causes at least half of scalp hair to be lost. It aims to see if the drug is safe and can help hair grow back.
This study tests an investigational drug to see if it can help people with severe alopecia areata, a condition that causes hair loss. It may help regrow hair.
This Phase 1/2 study tests whether a fecal microbiome transplant (FMT) can reduce active inflammation in people with Crohn’s disease. It’s designed for people who currently have signs of active bowel inflammation and can attend regular procedure visits.
This study tests an oral tablet called upadacitinib for people with severe alopecia areata who have lost at least half of their scalp hair. It aims to see if the drug can safely help hair regrow.
This trial tests whether transplanting healthy gut bacteria (called a fecal microbiota transplant, or FMT) can help people with advanced cancer who are losing weight and muscle. The goal is to see if it improves appetite and helps you maintain strength.
Hear when a new Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.